Hanlon L - Search Results

1

Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.

Blyth K, Vaillant F, Hanlon L, Mackay N, Bell M, Jenkins A, Neil JC, Cameron ER. Blyth K, et al. Among authors: hanlon l. Cancer Res. 2006 Feb 15;66(4):2195-201. doi: 10.1158/0008-5472.CAN-05-3558. Cancer Res. 2006. PMID: 16489021

2

The Runx genes as dominant oncogenes.

Cameron ER, Blyth K, Hanlon L, Kilbey A, Mackay N, Stewart M, Terry A, Vaillant F, Wotton S, Neil JC. Cameron ER, et al. Among authors: hanlon l. Blood Cells Mol Dis. 2003 Mar-Apr;30(2):194-200. doi: 10.1016/s1079-9796(03)00031-7. Blood Cells Mol Dis. 2003. PMID: 12732183 Review.

3

Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas.

Stewart M, Mackay N, Hanlon L, Blyth K, Scobie L, Cameron E, Neil JC. Stewart M, et al. Among authors: hanlon l. Cancer Res. 2007 Jun 1;67(11):5126-33. doi: 10.1158/0008-5472.CAN-07-0433. Cancer Res. 2007. PMID: 17545590 Free PMC article.

4

Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts.

Kilbey A, Blyth K, Wotton S, Terry A, Jenkins A, Bell M, Hanlon L, Cameron ER, Neil JC. Kilbey A, et al. Among authors: hanlon l. Cancer Res. 2007 Dec 1;67(23):11263-71. doi: 10.1158/0008-5472.CAN-07-3016. Cancer Res. 2007. PMID: 18056452 Free PMC article.

5

Runx1 promotes B-cell survival and lymphoma development.

Blyth K, Slater N, Hanlon L, Bell M, Mackay N, Stewart M, Neil JC, Cameron ER. Blyth K, et al. Among authors: hanlon l. Blood Cells Mol Dis. 2009 Jul-Aug;43(1):12-9. doi: 10.1016/j.bcmd.2009.01.013. Epub 2009 Mar 9. Blood Cells Mol Dis. 2009. PMID: 19269865

6

Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro.

Hanlon L, Barr NI, Blyth K, Stewart M, Haviernik P, Wolff L, Weston K, Cameron ER, Neil JC. Hanlon L, et al. J Virol. 2003 Jan;77(2):1059-68. doi: 10.1128/jvi.77.2.1059-1068.2003. J Virol. 2003. PMID: 12502821 Free PMC article.

7

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.

Dunham SP, Flynn JN, Rigby MA, Macdonald J, Bruce J, Cannon C, Golder MC, Hanlon L, Harbour DA, Mackay NA, Spibey N, Jarrett O, Neil JC. Dunham SP, et al. Among authors: hanlon l. Vaccine. 2002 Feb 22;20(11-12):1483-96. doi: 10.1016/s0264-410x(01)00507-2. Vaccine. 2002. PMID: 11858854

8

Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

Hanlon L, Argyle D, Bain D, Nicolson L, Dunham S, Golder MC, McDonald M, McGillivray C, Jarrett O, Neil JC, Onions DE. Hanlon L, et al. J Virol. 2001 Sep;75(18):8424-33. doi: 10.1128/jvi.75.18.8424-8433.2001. J Virol. 2001. PMID: 11507187 Free PMC article.

9

Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53.

Licciulli S, Avila JL, Hanlon L, Troutman S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, Capobianco AJ, Kissil JL. Licciulli S, et al. Among authors: hanlon l. Cancer Res. 2013 Oct 1;73(19):5974-84. doi: 10.1158/0008-5472.CAN-13-1384. Epub 2013 Aug 13. Cancer Res. 2013. PMID: 23943799 Free PMC article.

10

Requirement for Rac1 in a K-ras induced lung cancer in the mouse.

Kissil JL, Walmsley MJ, Hanlon L, Haigis KM, Bender Kim CF, Sweet-Cordero A, Eckman MS, Tuveson DA, Capobianco AJ, Tybulewicz VL, Jacks T. Kissil JL, et al. Among authors: hanlon l. Cancer Res. 2007 Sep 1;67(17):8089-94. doi: 10.1158/0008-5472.CAN-07-2300. Cancer Res. 2007. PMID: 17804720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page